InternationalUSRemember you can easily switch between MIP US and MIP International at any time

Biosimilar debate heats up at BIO

Speakers at the 2008 BIO International Convention in San Diego yesterday discussed the regulatory and scientific issues created by generic biological drugs, commonly known as biosimilars or follow-on biologics

Biosimilars are products that attempt to replicate biologics – medicines which involve living organisms – and are similar, but not identical to, the innovator drug. Like their pharmaceutical counterparts, they are offered at discounted prices to patients.

But because biosimilars...

Please log in to read the rest of this article.

New to Managing Intellectual Property? Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.

Already registered?

Please make sure you log in to read the rest of the article.

Log in

Join us now

Gain FREE access to up to five free articles when you register now.

Join here

Latest Country Updates


Most read articles